Independence Bank of Kentucky’s Teva Pharmaceuticals TEVA Stock Holding History

Independence Bank of Kentucky’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.9K	Hold	1,000	–	–	﹤0.01%	420
2026 Q1	$30.1K	Sell	1,000 -66	-6%	-$2.12K	﹤0.01%	454
2025 Q4	$33.3K	Buy	1,066 +66	+7%	+$1.63K	﹤0.01%	444
2025 Q3	$20.2K	Hold	1,000	–	–	﹤0.01%	487
2025 Q2	$16.8K	Hold	1,000	–	–	﹤0.01%	491
2025 Q1	$15.4K	Hold	1,000	–	–	﹤0.01%	489
2024 Q4	$22K	Hold	1,000	–	–	﹤0.01%	468
2024 Q3	$18K	Buy	+1,000	New	+$17.5K	﹤0.01%	441
2019 Q3	–	Sell	-300	Closed	-$3K	–	365
2019 Q2	$3K	Sell	300 -100	-25%	-$1.21K	﹤0.01%	299
2019 Q1	$6K	Sell	400 -200	-33%	-$3.53K	﹤0.01%	286
2018 Q4	$9K	Hold	600	–	–	0.01%	263
2018 Q3	$13K	Hold	600	–	–	0.01%	263
2018 Q2	$15K	Hold	600	–	–	0.01%	239
2018 Q1	$10K	Hold	600	–	–	0.01%	276
2017 Q4	$11K	Buy	+600	New	+$9.03K	0.01%	253

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Independence Bank of Kentucky's TEVA Position: Q2 2026 in Review

Independence Bank of Kentucky held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 1,000 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Independence Bank of Kentucky first reported a position in TEVA in Q4 2017 and has held it in 15 quarters since. 506 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Independence Bank of Kentucky held 1,000 shares of Teva Pharmaceuticals worth $33.9K as of Q2 2026.
Independence Bank of Kentucky left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #420 holding.
Independence Bank of Kentucky first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 15 quarters since.
506 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.